Dec workshop sold out

The next Diagnostic Evidence Workshop will be held on 28-29 September 2017 at Worcester College, Oxford.

This course is aimed at all professionals working on diagnostic tests including those working in industry, academia, funding and regulation.

Over two days, learn about the latest information on what evidence is needed to obtain regulatory approval, how NICE evaluates new diagnostic technology and how to collect evidence to support adoption in routine clinical practice. In addition you will be taught about different study designs including quality assessment and where to look for funding opportunities. The course combines talks with hands-on activities. To stimulate interactive discussions and maximise the learning experience, the number of places for this course are limited to 25 spaces.


Feedback from the 2016 course:

'Excellent, very relevant and presented in a usable and practical format'

'Relevant and met expectations'

'Excellent presentation on different forms of evidence and their importance'

'Excellent networking opportunity; overwhelmed by positivity and willingness to help from all parties; thank you!'

 'Beautiful setting, good content and very easy access'


Accommodation for the night of Thursday 28th September is included in the course fee. If you would like to stay for an extra night please contact as soon as possible. Alternatively there are several B&B options close by:

University rooms

Oxford B&B

Join the waiting list

The Diagnostic Evidence Workshop 2017 is now sold out but you may join the waiting list by emailing  If a space becomes available we will contact you to let you know.


Confirmed topics for this workshop include:

  • Tests as part of a clinical pathway
  • Aligning research and development with clinical needs
  • How to avoid low quality studies
  • Searching for existing evidence to support regulatory approval and other purposes
  • Basic statistics for diagnostic medicine
  • Evidence for regulatory purposes: CE marking and European IVD directive
  • Evidence for implementation in routine clinical practice- NICE evaluations
  • Possibilities of routinely available data
  • Health economic modelling
  • Funding for diagnostic test development/opportunities for collaboration with academia